On July 7 and 8, Brazil and India held joint consultations with the European Union in Geneva, within the “EU – Seizure of Generic Drugs in Transit” dispute (DS409).

Throughout the consultations and based on a list of nearly two hundred questions that were forwarded in advance, Brazil questioned several aspects of the European legislation on the seizure of drugs in transit through the Community territory, under alleged suspicion of violations of intellectual property rules.

The queries aimed at clarifying factual and interpretative aspects with regard to the actions of the customs officials, the jurisprudence of national courts and of the European Court of Justice. The goal of the consultations was also to obtain from the EU relevant documents for the understanding of the case.